Clinical Trial

Intraoperative Midazolam on Delirium Outcome of Elderly Patients

Study acronym: IMODE
Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study was a multicenter, randomized, double-blind, placebo-controlled trial to treat elderly surgical patients with low-dose midazolam or placebo for anesthesia induction. The incidence of postoperative 7-day delirium was assessed and compared between two groups, to provide valuable reference for clinical practitioners in the use of midazolam in elderly surgical patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-06; most recent amendment 2026-07-20.
Status change: Recruiting → Completed 2026-07-20
Status change: Not Yet Recruiting → Recruiting 2025-09-22
Trial Details
NCT Number NCT06963112
Lead Sponsor Chinese PLA General Hospital
Collaborators: Changhai Hospital, China-Japan Union Hospital, Jilin University, The First Affiliated Hospital of Nanchang University, First Affiliated Hospital of Guangxi Medical University, Second Hospital of Jilin University
Conditions Delirium, Anxiety
Enrollment 612 participants
Start Date 2025-04-01
Primary Completion 2026-05-22 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22